HAIER BIOMEDICAL(SH:688139) Cai Jing Wang·2025-11-11 06:08Core Insights - The article emphasizes that ESG has evolved from an additional requirement to a core competitive necessity for Chinese enterprises, with Haier Biomedical showcasing a model of integrating ESG into sustainable growth through technology-driven practices [1][7] - Haier Biomedical's approach to ESG is rooted in its technological advancements, demonstrating that ESG can be a product of continuous innovation rather than a separate cost center [1][2] Group 1: Technological Innovation and ESG - Haier Biomedical's Eco-Drive technology has improved energy efficiency by 30%, achieving the highest efficiency level globally while maintaining operational stability [2] - The daily energy consumption of a low-temperature refrigerator has decreased from over 20 kWh in 2005 to 4.165 kWh in 2024, marking an 80% reduction over 20 years [2] - The ART intelligent control technology in stability test boxes has achieved an 80% energy savings while maintaining strict temperature control [2][3] Group 2: Economic Benefits and Efficiency - The energy savings from a new ultra-low temperature refrigerator can cover its initial purchase cost within approximately 6.7 years, saving 2.2 million yuan over ten years for a medium-sized sample library [3] - For a large sample library with 400 units, the savings can reach 11.2 million yuan over the same period, demonstrating the economic benefits of energy-efficient technologies [3] Group 3: Comprehensive ESG Integration - Haier Biomedical integrates ESG throughout its entire value chain, from procurement to manufacturing, logistics, and product lifecycle [4][5] - The company promotes "green procurement agreements" with suppliers, emphasizing the use of environmentally friendly materials and local sourcing to reduce carbon emissions [4] - The establishment of a national-level "green factory" and the largest low-temperature cold chain base in the Asia-Pacific region further exemplifies its commitment to reducing operational carbon footprints [4] Group 4: Global Impact and Innovation - Haier Biomedical has developed solar-powered vaccine refrigerators to address storage challenges in regions with inadequate electricity coverage, ensuring vaccine safety even in extreme conditions [6] - The company has expanded its services to over 160 countries, showcasing Chinese innovation in global public health solutions [6] - The launch of the "green ecological co-construction initiative" at the Import Expo signifies a collaborative approach to sustainability within the industry [6] Group 5: Lessons for the Industry - Haier Biomedical's ESG practices provide a replicable model for Chinese listed companies, emphasizing the integration of technological innovation with business growth [7] - The company's journey illustrates that ESG is not merely a reporting obligation but a fundamental aspect of operational strategy and product development [7] - The deep integration of ESG into business operations positions Haier Biomedical favorably in attracting long-term investors in the capital market [7]